Evidence map›Paper›PMID 11160015›Full record

ArticleInfection and immunity2001

Expression of tumor necrosis factor alpha and interleukin 1 beta in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms.

P Robinson, P C Okhuysen, C L Chappell, D E Lewis, I Shahab, A Janecki, A C White

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 49 citations in OpenAlex.

  1. Microphysiological gut-on-chip enables extendedFrontiers in cellular and infection microbiology · 2025
    Article
  2. Review
  3. Article
  4. A rapid IL-17 response to Cryptosporidium parvum in the bovine intestine.Veterinary immunology and immunopathology · 2017
    Article
  5. Cryptosporidiosis-an overview.Journal of biomedical research · 2012
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

P RobinsonDepartment of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.
P C Okhuysen
C L Chappell
D E Lewis
I Shahab
A Janecki
A C White
Baylor College of Medicine · USThe University of Texas Health Science Center at Houston · US

Funding

Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Zolmitriptan challenge and human performance testingM01RR002558 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SCHULTZ, STANLEY G · 1985 to 2006
$10.3M
INTESTINAL CYTOKINES IN CRYPTOSPORIDIOSISR01AI041735 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI WHITE, ARTHUR CLINTON · 1997 to 2005
$1.9M
NCRR NIH HHS M01 RR002558NCRR NIH HHS RR02558NIAID NIH HHS AI36211NIAID NIH HHS P30 AI036211NIAID NIH HHS R01 AI041735NIAID NIH HHS R01 AI41735
6 · The paper itself

Abstract

Jejunal biopsies from volunteers challenged with Cryptosporidium parvum were examined for tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-1 beta mRNA. Postchallenge biopsies from 15 of 28 (54%) volunteers expressed TNF-alpha; 14% expressed IL-1 beta. Cytokine expression did not correlate with enteric symptoms, suggesting that TNF-alpha and IL-1 beta are not key mediators of diarrhea in human cryptosporidiosis.

Indexed as

Cryptosporidium parvumAnimalsBiopsyCryptosporidiosisDiarrheaHumansInterleukin-1Interleukin-15JejunumRNA, MessengerTumor Necrosis Factor-alphaInterleukin-1Interleukin-15RNA, MessengerTumor Necrosis Factor-alpha

Identifiers

PMID11160015
PMCPMC97999
OpenAlexW2150175458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.